Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

223
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

385
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
385
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

196
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
196
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

257
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
257
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

234
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
234
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

352
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
352

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lower AKI Risk and Higher Survival With Microaxial Flow Pump Support During Elective PCI: A Propensity Score-Matched Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Depth of neutrophil mobilization stratifies survival in ST-elevation myocardial infarction.

Nature cardiovascular research·2026
Same author

Response Letter: Interpreting Echocardiographic Right Ventricular-Pulmonary Arterial Coupling Indices After Transcatheter Tricuspid Intervention.

Structural heart : the journal of the Heart Team·2026
Same author

Congestion, but not low cardiac output, is independently associated with acute kidney injury following contrast agent exposure.

Frontiers in cardiovascular medicine·2026
Same author

Beyond infarct size: redefining post-infarction remodelling in the era of multiparametric CMR.

European heart journal. Cardiovascular Imaging·2026
Same author

Carbon dioxide is a triple vasodilator.

Cardiovascular research·2026

Related Experiment Video

Updated: Jan 9, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K

A Simplified Frailty Measure Improves Risk Stratification in Patients Undergoing Percutaneous Mitral Valve Repair.

Clemens Metze1, Elric Zweck2, Christos Iliadis1

  • 1Department of Cardiology, Heart Center Cologne, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.

Journal of Cachexia, Sarcopenia and Muscle
|December 2, 2025
PubMed
Summary
This summary is machine-generated.

A simplified frailty measure, including exhaustion and slowness, significantly improved risk prediction for mortality and heart failure hospitalization in patients undergoing percutaneous mitral valve repair (PMVR). This frailty assessment should be integrated into clinical decision-making for severe mitral regurgitation.

Keywords:
MitraClipfrailtypercutaneous mitral valve repairrisk score

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.2K
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.1K

Related Experiment Videos

Last Updated: Jan 9, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.3K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.2K
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

1.1K

Area of Science:

  • Cardiology
  • Geriatrics
  • Clinical Risk Prediction

Background:

  • Current risk prediction models for percutaneous mitral valve repair (PMVR) based on organ morbidity have moderate performance.
  • There is a need for improved risk stratification in patients undergoing PMVR.

Purpose of the Study:

  • To examine the utility of frailty measures for risk prediction in patients undergoing PMVR.
  • To assess the additive predictive performance of frailty domains over the existing MitraScore.

Main Methods:

  • Prospective assessment of frailty domains (exhaustion, slowness, inactivity, weakness, weight loss) in patients undergoing PMVR.
  • Examination of the association between frailty domains and mortality/heart failure hospitalization (HFH).
  • Evaluation of a simplified frailty (S-frailty) measure for its predictive performance compared to the MitraScore.

Main Results:

  • Exhaustion, slowness, inactivity, and weakness were significantly associated with increased risk of mortality and HFH.
  • A simplified frailty (S-frailty) measure derived from exhaustion and slowness independently predicted mortality and HFH.
  • Adding S-frailty to the MitraScore significantly improved the prediction of mortality and 1-year mortality risk.

Conclusions:

  • A simplified frailty measure combining exhaustion and gait speed enhances risk prediction in PMVR patients.
  • Frailty assessment should be incorporated into clinical decision-making and risk scores for patients with severe mitral regurgitation.